MyFinsight
Home
Blog
About
Maturities of investments
$43,065K
(202.21%↑ Y/Y)
Proceeds from espp
offerings
$338K
(71.57%↑ Y/Y)
Net proceeds from
stock option...
$23K
Net cash provided by
(used in) investing...
$24,030K
(153.43%↑ Y/Y)
Net cash provided by
financing activities
$361K
(-94.17%↓ Y/Y)
Canceled cashflow
$19,035K
Net change in cash,
cash equivalents,...
-$16,655K
(87.09%↑ Y/Y)
Canceled cashflow
$24,391K
Stock-based compensation
expense
$4,865K
(-59.48%↓ Y/Y)
Non-cash lease expense
$2,866K
(-39.80%↓ Y/Y)
Depreciation expense
$1,785K
(-49.92%↓ Y/Y)
Accrued expenses and
other current...
$880K
(152.07%↑ Y/Y)
Prepaid expenses and
other current assets
-$659K
(-1.07%↓ Y/Y)
Purchases of investments
$18,989K
(-65.62%↓ Y/Y)
Purchases of property and
equipment
$46K
(-98.85%↓ Y/Y)
Net cash used in
operating activities
-$41,046K
(54.53%↑ Y/Y)
Canceled cashflow
$11,055K
Net loss
-$42,109K
(59.70%↑ Y/Y)
Accounts payable
-$6,518K
(-346.13%↓ Y/Y)
Lease liabilities
-$2,034K
(0.93%↑ Y/Y)
Deferred revenue related
party
-$1,128K
(53.64%↑ Y/Y)
Amortization of premiums and
discount on short-term...
$312K
(-45.74%↓ Y/Y)
Back
Back
Cash Flow
Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME)
source: myfinsight.com